Prof. Jaleel Kareem Ahmed
Jaleel Kareem Ahmed has completed his Ph.D. from Baghdad University. He is the Dean of the Institute of Foundry and Hammering. He has registered 8 patients with 40 published papers and 3 books. He is a member of Who is Who network. He is a reviewer in Jon Wily and Sons and Editorial Board Member of Science Publishing Group and a member in Encyclopedia of Chemistry Scientists. He has got the Iraqi Scientist Medal. Currently, he is also a Professor of physical chemistry in the College of Materials Engineering, Babylon University, Iraq.
Alzahra Cancer Center Dubai,
Dr Alrawi is currently the Director of all Surgical Oncology Services at Alzahra Cancer Center in the Heart of Dubai and its tertiary referral cancer center for all UAE, hosting highly specialized surgical oncology subspecialties, including Colorectal, Breast Oncology, Head & Neck Surgery, Urology, Gynecological Oncology, Sarcoma/ Melanoma and Peritoneal surface malignancy, in addition to pancreatic and hepatic surgery. DR Alrawi was the Chief of Surgical Oncology Divison at Tawam Hospital and was the interim chair of the department of surgery from October 2013-September 2015. Tawam Hospital is affiliated with JOHN HOPKINS Medical System. Dr. Alrawi major interest in Gastrointestinal Oncology, including Esophageal, Gastric, Pancreas, Liver and colonic surgery with special interest in endocrine surgery including thyroid, parathyroid and adrenal surgery, Sadir Alrawi, was the Chief of the Surgical Oncology Program at Comprehensive Cancer Center of 21st Century in Jacksonville, Florida from 2008- 2013. Prior to that, Dr. Alrawi was an assistant professor in the Department of Surgery/Division of Surgical Oncology at the University of Florida, Jacksonville.
Dr. Alvaro Macieira-Coelho
French National Institute of Health
Dr. Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received an MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He made an internship at the University Hospital in Lisbon and was a research associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a visiting Professor at the University of Linkoping (Sweden). He published 150 papers in professional Journals and 9 books on cancer and aging. He received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science” Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).
Prof. Suraiya Rasheed
University of Southern California
Suraiya Rasheed is a Professor and Director of Viral Oncology and Proteomics Laboratory in the Department of Pathology at the Keck School of Medicine, University of Southern California, Los Angeles, USA. She has graduated with honors and received her fi rst PhD from Osmania University, Hyderabad, India and second PhD from London University and FRCPath from the Royal College of Pathology, London. She has also served numerous national and international Advisory Committees including Study Sections of the National Cancer Institute, National Institute of Allergy and Infectious Diseases, Antiviral Drug Development and Drug- Screening Programs for AIDS and Abstract Reviewing Committee for the International AIDS Society’s conferences.
Prof. Upender Manne
University of Alabama
Prof. Upender Manne obtained his M.S. (Biochemistry, Histochemistry, Parasitology, Zoonosis) and Ph.D. (energy metabolic pathways of endoparasites) degrees from Osmania University, Hyderabad, India. His postdoctoral training was in molecular immunology and vaccine development for malaria (Malaria Research Center, Delhi, India); in helicobacter infections (School of Microbiology, University of New South Wales, Sydney, Australia); and in histopathology, molecular tumor biology, and preclinical translational research of human malignancies at the University of Alabama at Birmingham (UAB). He also received certification in bioinformatics at UAB. Dr. Manne’s research on racial disparity in CRC has received considerable national and international recognition. In 2009, the Presidents Cancer Panel invited Dr. Manne to speak on “Biologic differences between ethnic groups and their clinical implications in cancer care,” and devoted to the topic, “America’s demographic and cultural transformation: implications for the cancer enterprise.” Currently, he is the Lead Principal Investigator of two Comprehensive Cancer Research Partnership between UAB Comprehensive Cancer Center and Tuskegee University, Tuskegee, AL and Morehouse School of Medicine, Atlanta, GA (U54); and Alabama State University, Montgomery, AL (P20) to Reduce Cancer Health Disparities by implementing innovative, multi-disciplinary, collaborative, population-based cancer control and prevention research and has contributed to education, training, and community outreach activities. These two programs are funded by the National Cancer Institute of the National Institute of Health.
Prof. Wancai Yang
Jining Medical University,
My lab studies molecular mechanisms of gastrointestinal carcinogenesis and progression. Specifically, using Muc2 knockout and carcinogen-induced mouse models of chronic colitis and colorectal cancer, we have identified that chronic colitis malignant transformation might be resulted from genetic and epigenetic alterations and activation of oncogenic signaling (e.g. Wnt/beta-catenin and inflammatory pathways). The changes of expression and functions of the potential key biomarkers have been validated in tissue microarray (TMA), in vitro and in vivo. In addition, we have also identified that intestinal microbe disorder is linked to colitis-associated colorectal cancer. Moreover, genetic alterations, particularly, single nucleotide polymorphisms (SNPs), play critical roles in esophageal carcinogenesis and progression.